Advertisement

Topics

Further Iclaprim Analyses Ahead Of Crucial Months For Motif Bio

04:38 EDT 17 Apr 2019 | SCRIP

A 3 May meeting with the FDA is likely to be crucial for the future commercialization strategy for the biotech’s...

      

Related Stories

 

Original Article: Further Iclaprim Analyses Ahead Of Crucial Months For Motif Bio

NEXT ARTICLE

More From BioPortfolio on "Further Iclaprim Analyses Ahead Of Crucial Months For Motif Bio"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...